Rybrevant 50 MG/ML per 7 ML Injection

RxCUI
2549739
RxNorm name
Rybrevant 50 MG/ML per 7 ML Injection
Display name
Rybrevant 50 MG/ML per 7 ML Injection
Full name
Rybrevant 50 MG/ML per 7 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761210Rybrevantamivantamab-vmjw351(a)Rx2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RybrevantAMIVANTAMAB-VMJWJanssen Biotech, Inc.1466c070-9f97-4fa4-a955-6a6b59981fb82025-11-11Warnings, Adverse reactionsExact identifier
rxcui: 2549739

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
1466c070-9f97-4fa4-a955-6a6b59981fb8Rybrevant 350 MG in 7 ML Injection [PSN] · 7 ML amivantamab-vmjw 50 MG/ML Injection [Rybrevant] [SBD] · Rybrevant 350 MG per 7 ML Injection [SY] · Rybrevant 50 MG/ML per 7 ML Injection [SY]416These highlights do not include all the information needed to use RYBREVANT safely and effectively. See full prescribing information for RYBREVANT. RYBREVANT ® (amivantamab-vmjw) injection, for intravenous use Initial U.S. Approval: 202120251111